Reina Benabou - Net Worth and Insider Trading

Reina Benabou Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Reina Benabou owns 1 companies in total, including BioXcel Therapeutics Inc (BTAI) .

Click here to see the complete history of Reina Benabou’s form 4 insider trades.

Insider Ownership Summary of Reina Benabou

Ticker	Comapny	Transaction Date	Type of Owner
BTAI	BioXcel Therapeutics Inc	2020-06-22	See Remarks

Reina Benabou Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Reina Benabou Ownership Network

Ownership Network List of Reina Benabou

No Data

Ownership Network Relation of Reina Benabou

Reina Benabou Owned Company Details

What does BioXcel Therapeutics Inc do?

Who are the key executives at BioXcel Therapeutics Inc?

Reina Benabou is the See Remarks of BioXcel Therapeutics Inc. Other key executives at BioXcel Therapeutics Inc include CHIEF COMMERCIAL OFFICER Matthew T. Wiley , Chief Financial Officer Richard I Steinhart , and Chief Scientific Officer Frank Yocca .

BioXcel Therapeutics Inc (BTAI) Insider Trades Summary

Over the past 18 months, Reina Benabou made no insider transaction in BioXcel Therapeutics Inc (BTAI). Other recent insider transactions involving BioXcel Therapeutics Inc (BTAI) include a net sale of 1,503,378 shares made by Vimal Mehta , a net sale of 13,972 shares made by Richard I Steinhart , and a net sale of 10,366 shares made by Javier Rodriguez .

In summary, during the past 3 months, insiders sold 36,432 shares of BioXcel Therapeutics Inc (BTAI) in total and bought 0 shares, with a net sale of 36,432 shares. During the past 18 months, 1,550,438 shares of BioXcel Therapeutics Inc (BTAI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,550,438 shares.

BioXcel Therapeutics Inc (BTAI)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioXcel Therapeutics Inc Insider Transactions

No Available Data

Reina Benabou Mailing Address

Above is the net worth, insider trading, and ownership report for Reina Benabou. You might contact Reina Benabou via mailing address: C/o Bioxcel Therapeutics, Inc., 555 Long Wharf Drive, New Haven Ct 06511.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.